Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

419 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High resection rates of colorectal liver metastases after standardized follow-up and multimodal management: an outcome study within the COLOFOL trial.
Scherman P, Hansdotter P, Holmberg E, Viborg Mortensen F, Petersen SH, Rizell M, Naredi P, Syk I; COLOFOL study group. Scherman P, et al. Among authors: holmberg e. HPB (Oxford). 2023 Jul;25(7):766-774. doi: 10.1016/j.hpb.2023.03.003. Epub 2023 Mar 9. HPB (Oxford). 2023. PMID: 36967324 Free article. Clinical Trial.
Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer: a secondary analysis of a randomized clinical trial.
Stenmark Tullberg A, Sjöström M, Tran L, Niméus E, Killander F, Kovács A, Lundstedt D, Holmberg E, Karlsson P. Stenmark Tullberg A, et al. Among authors: holmberg e. J Immunother Cancer. 2023 May;11(5):e006618. doi: 10.1136/jitc-2022-006618. J Immunother Cancer. 2023. PMID: 37208129 Free PMC article. Clinical Trial.
Protocol for the T-REX-trial: tailored regional external beam radiotherapy in clinically node-negative breast cancer patients with 1-2 sentinel node macrometastases - an open, multicentre, randomised non-inferiority phase 3 trial.
Alkner S, de Boniface J, Lundstedt D, Mjaaland I, Ryden L, Vikstrom J, Bendahl PO, Holmberg E, Sackey H, Wieslander E, Karlsson P. Alkner S, et al. Among authors: holmberg e. BMJ Open. 2023 Sep 26;13(9):e075543. doi: 10.1136/bmjopen-2023-075543. BMJ Open. 2023. PMID: 37751948 Free PMC article.
Effect of once-per-day tacrolimus versus twice-per-day ciclosporin on 3-year incidence of chronic lung allograft dysfunction after lung transplantation in Scandinavia (ScanCLAD): a multicentre randomised controlled trial.
Dellgren G, Lund TK, Raivio P, Leuckfeld I, Svahn J, Holmberg EC, Olsen PS, Halme M, Fiane A, Lindstedt S, Riise GC, Magnusson J. Dellgren G, et al. Lancet Respir Med. 2024 Jan;12(1):34-44. doi: 10.1016/S2213-2600(23)00293-X. Epub 2023 Sep 10. Lancet Respir Med. 2024. PMID: 37703908 Clinical Trial.
Malignancies After Lung Transplantation.
Stenman C, Wallinder A, Holmberg E, Karason K, Magnusson J, Dellgren G. Stenman C, et al. Among authors: holmberg e. Transpl Int. 2024 Sep 9;37:12127. doi: 10.3389/ti.2024.12127. eCollection 2024. Transpl Int. 2024. PMID: 39314925 Free PMC article.
Validation of a breast cancer assay for radiotherapy omission: an individual participant data meta-analysis.
Karlsson P, Fyles A, Chang SL, Arrick B, Baehner FL, Malmström P, Fernö M, Holmberg E, Sjöström M, Liu FF, Cameron DA, Williams LJ, Bartlett JM, Dunlop J, Caldwell J, Loane JF, Mallon E, Piper T, Kunkler I, Feng FY, Speers CW, Pierce LJ, Bennett JP, Taylor KJ. Karlsson P, et al. Among authors: holmberg e. J Natl Cancer Inst. 2024 Oct 18:djae262. doi: 10.1093/jnci/djae262. Online ahead of print. J Natl Cancer Inst. 2024. PMID: 39423142
419 results